secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-12-04T23:59:59+00:00
Accession:  0001628280-25-055215
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics appoints Jeff Sacher as interim CFO effective Dec 3, 2025
------------------------------------------------------------------------------

- Jeff Sacher appointed as Treasurer and interim CFO, effective immediately; company continues search for permanent CFO.
- Sacher is a CFO at Danforth Advisors, which will be paid an hourly rate for interim CFO services plus expenses.
- Sacher has 35 years in biotech and investment banking, with an MBA from Kellogg and a BA from Cornell.
- No family relationships with any executive officers or directors; no other arrangements for his appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025055215/0001628280-25-055215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025055215/fhtx-20251203.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-055215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer